Straight talk: Pfizer translates high science into plain language to make study data easier to read

Finding clinical trial results for a specific drug can be challenging—but reading through them can be even more daunting. Scientific lingo and tongue-twisting terms can frustrate even the most intelligent patient.

Pfizer’s been working on the issue for a decade, but is now expanding its efforts. In May, it started sharing clinical study results in plain language in a searchable online portal open to the public. Starting next year, it will disclose all trial results using plain language summaries and begin translating them into Spanish, French and German.